[Federal Register Volume 86, Number 166 (Tuesday, August 31, 2021)]
[Notices]
[Page 48746]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18727]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Center for 
Advancing Translational Sciences Advisory Council.
    The meeting will be open to the public as indicated below. The open 
session will be videocast and can be accessed from the NIH Videocasting 
and Podcasting website (http://videocast.nih.gov). Individuals who need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should notify the Contact Person listed 
below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Advisory Council.
    Date: September 23-24, 2021.
    Closed: September 23, 2021, 10:30 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, 6701 Democracy 
Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting).
    Open: September 23, 2021, 1:00 p.m. to 5:00 p.m.
    Agenda: Report from the Institute Director and other staff.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, 6701 Democracy 
Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting).
    Open: September 24, 2021, 1:00 p.m. to 5:00 p.m.
    Agenda: To view and discuss Clearance of Concepts.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, 6701 Democracy 
Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive 
Secretary, National Center for Advancing Translational Sciences, One 
Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809, 
<a href="/cdn-cgi/l/email-protection#f899969699d68a99958b9d819d8f91969fb8969190d69f978e"><span class="__cf_email__" data-cfemail="b1d0dfdfd09fc3d0dcc2d4c8d4c6d8dfd6f1dfd8d99fd6dec7">[email protected]</span></a>.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice no later than 15 days after the meeting at 
<a href="/cdn-cgi/l/email-protection#337d70726760705c465d505a5f7a5d434647735e525a5f1d5d5a5b1d545c45"><span class="__cf_email__" data-cfemail="08464b495c5b4b677d666b61644166787d7c486569616426666160266f677e">[email protected]</span></a>. The statement should include the 
name, address, telephone number and when applicable, the business or 
professional affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: August 25, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-18727 Filed 8-30-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>